Blanket purchase agreement for radiopharmaceutical supplies

Active Blanket Purchase Agreement Awarded Last action

Contract number
HT001425AE003
Awardee
Awarding agency
Task orders
3 $334,164 obligated

Award facts

Combined order value
$334,164 Current and potential, with all options
Last date to order 22% complete
IDV ceiling 4% used
$7,500,000.00
Maximum order
$300,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency established a Blanket Purchase Agreement with Cardinal Health 414, LLC on September 15, 2025, with a ceiling value of $7.5 million and an ultimate completion date of September 14, 2030, for radiopharmaceutical supplies.

Cardinal Health 414, LLC is a subsidiary of Cardinal Health, Inc., headquartered in Dublin, Ohio, and specializes in the manufacturing, testing, and distribution of radiopharmaceuticals and medical isotopes to federal healthcare agencies. The company holds Nuclear Regulatory Commission licensing and FDA approval for radiopharmaceutical products and maintains strict compliance with Department of Transportation regulations for radioactive materials transport.

The BPA covers comprehensive radiopharmaceutical products including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 fluorodeoxyglucose (FDG), and gallium-67, along with specialized therapeutic radiopharmaceuticals such as Xofigo (radium-223 dichloride) and Lymphoseek for diagnostic imaging. The company operates as a critical single-source supplier for certain proprietary products, enabling sole-source procurements while maintaining effective supply chain management for essential nuclear medicine and diagnostic imaging support across federal military treatment facilities.

Performance occurs from Cardinal Health 414's primary facility in Dublin, Ohio, with delivery to military treatment facilities. The agreement supports both scheduled routine deliveries and emergency orders, often with delivery requirements as stringent as one to one-and-a-half hour turnaround times to accommodate the short half-lives of radioactive isotopes.

A BPA call issued on November 29, 2025, valued at $249,980.88, procured radiopharmaceutical imaging agents and radioactive agents for the nuclear medicine and radiology department at Bethesda, Maryland, with completion by November 28, 2026.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 · Radiopharmaceutical supplies $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 · Radiopharmaceutical supplies $0
Original award $0

Quick answers

Who was awarded contract HT001425AE003?

HT001425AE003 was awarded to Cardinal Health 414, LLC by Defense Health Agency (Department of Defense) on September 15, 2025.

How much is contract HT001425AE003 worth?

Orders under HT001425AE003 have obligated $334,164. HT001425AE003's own ceiling is $7,500,000. A single order can be worth up to $300,000.

How many orders have been placed under contract HT001425AE003?

3 orders have been placed under HT001425AE003, the latest on June 9, 2026.

Who can order from contract HT001425AE003?

HT001425AE003 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV